Laura Antipov

Laura Antipov is a self-proclaimed “start-up junkie” with a passion for taking big ideas and translating them into clear, actionable plans. She has been in the biotech industry for 10 years, at three different early stage start-ups, always playing the same role: a “Jack-of-all-trades” problem solver. Laura joined Auron in January 2019; prior to that, she was the Director of Science at Riffyn, where she led collaborations with several global pharmaceutical companies and oversaw a breadth of drug development projects spanning exploratory research to process development. Prior to that, Laura helped build a drug discovery program from the ground up at Silver Creek Pharmaceuticals, a company she joined as employee #4. Her work at Silver Creek led to a clinical candidate currently in Phase 2 trials. Before joining industry, Laura performed postdoctoral research at Harvard Medical School where she studied protein structure/function relationships. Laura holds a Ph.D. in Biological Chemistry from MIT and bachelor’s degrees in both Chemistry and Mathematics from the University of Missouri.